Fig. 8From: Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-lowClinical and biological heterogeneities in HER2neg TNBC and HER2low TNBC. HER2low TNBC and HER2neg TNBC show distinct clinical features as well as different tumor properties, including tumor cell clusters, tumor hallmarks, and TMEsBack to article page